Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 393

1.

STAT1 Signaling in Astrocytes Is Essential for Control of Infection in the Central Nervous System.

Hidano S, Randall LM, Dawson L, Dietrich HK, Konradt C, Klover PJ, John B, Harris TH, Fang Q, Turek B, Kobayashi T, Hennighausen L, Beiting DP, Koshy AA, Hunter CA.

MBio. 2016 Nov 8;7(6). pii: e01881-16. doi: 10.1128/mBio.01881-16.

2.

Evaluation of Interleukin17and Interleukin 23 expression in patients with active and latent tuberculosis infection.

Heidarnezhad F, Asnaashari A, Rezaee SA, Ghezelsofla R, Ghazvini K, Valizadeh N, Basiri R, Ziaeemehr A, Sobhani S, Rafatpanah H.

Iran J Basic Med Sci. 2016 Aug;19(8):844-850.

3.

Deregulation of Interferon Signaling in Malignant Cells.

Katsoulidis E, Kaur S, Platanias LC.

Pharmaceuticals (Basel). 2010 Feb 4;3(2):406-418. Review.

5.
6.

Transcriptomic Study on Ovine Immune Responses to Fasciola hepatica Infection.

Fu Y, Chryssafidis AL, Browne JA, O'Sullivan J, McGettigan PA, Mulcahy G.

PLoS Negl Trop Dis. 2016 Sep 23;10(9):e0005015. doi: 10.1371/journal.pntd.0005015.

7.

Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.

Walker EC, Johnson RW, Hu Y, Brennan HJ, Poulton IJ, Zhang JG, Jenkins BJ, Smyth GK, Nicola NA, Sims NA.

J Biol Chem. 2016 Oct 7;291(41):21703-21716.

PMID:
27539849
8.

Constitutive IFNα/β signaling maintains expression of signaling intermediaries for efficient cytokine responses.

Messina NL, Clarke CJ, Johnstone RW.

JAKSTAT. 2016 May 18;5(1):e1173804. doi: 10.1080/21623996.2016.1173804.

PMID:
27512617
9.

Leptin-Induced JAK/STAT Signaling and Cancer Growth.

Mullen M, Gonzalez-Perez RR.

Vaccines (Basel). 2016 Jul 26;4(3). pii: E26. doi: 10.3390/vaccines4030026. Review.

10.

Modulation of Stat-1 in Human Macrophages Infected with Different Species of Intracellular Pathogenic Bacteria.

Schiavano GF, Dominici S, Rinaldi L, Cangiano AM, Brandi G, Magnani M.

J Immunol Res. 2016;2016:5086928. doi: 10.1155/2016/5086928.

11.

Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.

Falls T, Roy DG, Bell JC, Bourgeois-Daigneault MC.

ILAR J. 2016;57(1):73-85. doi: 10.1093/ilar/ilv048.

PMID:
27034397
12.

Herpes Simplex Virus and Interferon Signaling Induce Novel Autophagic Clusters in Sensory Neurons.

Katzenell S, Leib DA.

J Virol. 2016 Apr 14;90(9):4706-19. doi: 10.1128/JVI.02908-15.

13.

Response to interferons and antibacterial innate immunity in the absence of tyrosine-phosphorylated STAT1.

Majoros A, Platanitis E, Szappanos D, Cheon H, Vogl C, Shukla P, Stark GR, Sexl V, Schreiber R, Schindler C, Müller M, Decker T.

EMBO Rep. 2016 Mar;17(3):367-82. doi: 10.15252/embr.201540726.

14.

Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.

George CX, Ramaswami G, Li JB, Samuel CE.

J Biol Chem. 2016 Mar 18;291(12):6158-68. doi: 10.1074/jbc.M115.709014.

15.

Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules.

Spencer CT, Bezbradica JS, Ramos MG, Arico CD, Conant SB, Gilchuk P, Gray JJ, Zheng M, Niu X, Hildebrand W, Link AJ, Joyce S.

Proteomics Clin Appl. 2015 Dec;9(11-12):1035-52. doi: 10.1002/prca.201500106.

16.

Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide.

Madera S, Rapp M, Firth MA, Beilke JN, Lanier LL, Sun JC.

J Exp Med. 2016 Feb 8;213(2):225-33. doi: 10.1084/jem.20150712.

17.

Human IFNAR2 deficiency: Lessons for antiviral immunity.

Duncan CJ, Mohamad SM, Young DF, Skelton AJ, Leahy TR, Munday DC, Butler KM, Morfopoulou S, Brown JR, Hubank M, Connell J, Gavin PJ, McMahon C, Dempsey E, Lynch NE, Jacques TS, Valappil M, Cant AJ, Breuer J, Engelhardt KR, Randall RE, Hambleton S.

Sci Transl Med. 2015 Sep 30;7(307):307ra154. doi: 10.1126/scitranslmed.aac4227.

18.

IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.

Peters A, Fowler KD, Chalmin F, Merkler D, Kuchroo VK, Pot C.

J Immunol. 2015 Nov 1;195(9):4144-53. doi: 10.4049/jimmunol.1302246.

19.

STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.

Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Mueller M, Wormley FL Jr.

Infect Immun. 2015 Dec;83(12):4513-27. doi: 10.1128/IAI.00935-15.

20.
Items per page

Supplemental Content

Support Center